PUBLICATION

2020

Current Status of Chronic Kidney Disease

Abstract: Patients with chronic kidney disease (CKD) have a higher risk of mortality, mostly from cardiovascular complications. Currently, the biomarkers...

Renal effects of sulodexide-1.jpg

Background. Glycosaminoglycan plays an important role in the maintenance of glomerular charge selectivity of diabetic nephropathy. Sulodexide, a mixture of naturally occurring...

2019

Urinary biomarkers of tubular injury to

Background: Novel potential tubular biomarkers in diabetic nephropathy could improve risk stratification and
prediction...

role-1_edited.jpg

Background: The emerging renal and cardiovascular complications of type 2 diabetes (T2DM) genetics involves differently assembled gene variants including transcription factor 7-like 2 (TCF7L2)...

2018

Background: A very low protein diet (VLPD) with ketoacid analogs of essential amino acids (KA/EAA) administration
can remarkably influence protein synthesis and metabolic...

Background. Intensive glucose control reduces the risk for microvascular complications in type 2 diabetes (T2DM). Recently, sodium-glucose cotransporter 2 (SGLT2) inhibitors have been shown to exert renoprotection...

Background: Choices of hypoglycemic agents for patients with type 2 diabetes and chronic kidney disease (CKD) are limited. Available data among patients with CKD suggest that...

OBJECTIVE: Systolic hypertension is common in elderly patients and remains a challenge to treat effectively...

Patients with diabetic nephropathy have a higher risk of mortality, mostly from cardiovascular complications. Standard biomarkers including serum creatinine, estimated glomerular filtration rate, and albuminuria are imprecise, do not directly measure renal tissue injury...

Please reload

2017